The variations and/or mutations of m6A RNA methylation regulators occurring in the acute myeloid leukemia (AML) patients present a close relation with the mutations of TP53 may disclose the poor prognosis in AML (Kwok et al., 2017). This evidence concerns the gene TP53 and acute myeloid leukemia.